**Summary**
THG PLC announced the disposal of Claremont Ingredients to Nactarome Group for ยฃ103 million in cash, marking a significant return on investment since its acquisition in 2020 for ยฃ52 million. This move aligns with THGs strategy to simplify its portfolio and reduce net leverage. Claremont, a UK-based flavour manufacturing specialist, enhanced Myproteins product development capabilities, and its relationship with THG will be maintained through a long-term supply contract.
**Financial Highlights**
**H1 2025** Adjusted EBITDA of ยฃ24 million (down from ยฃ37.1 million in H1 2024) due to higher whey pricing. Cash and available facilities at ยฃ278 million, with net debt at ยฃ330 million (proforma ยฃ230 million post-disposal).
**H2 2025 Outlook** THG Nutrition expects 10-12% revenue growth, supported by stable whey prices and rising consumer prices. Myprotein will limit price increases to prioritize market share growth, with a ยฃ15 million investment in 2025, resulting in a Group adjusted EBITDA of ยฃ50 million for H2.
**FY 2026** Group EBITDA expected to adjust solely for Claremonts disposal, with a focus on operating leverage and market share gains.
**Strategic Updates**
THG Nutrition delivered double-digit revenue growth in June and July, with a focus on expanding Myproteins global offline retail presence from 34,000 to 100,000 doors.
THG Beauty also saw improved revenue growth in H2.
**CEO Comment**
Matthew Moulding highlighted Claremonts success in building Myproteins global licensing franchise and emphasized the disposals strategic alignment with THGs focus on core strengths and a strong balance sheet.
**About THG PLC**
THG is a global e-commerce group operating THG Beauty (platforms like Lookfantastic, Dermstore, Cult Beauty) and THG Nutrition (led by Myprotein), with a focus on health, wellness, and beauty categories.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text:
### Key Notes:
1. **Adjusted EBITDA**: H1 2025 decreased by ยฃ13.1m compared to H1 2024, primarily due to higher whey pricing in Nutrition.
2. **Net Debt**: Reduced by ยฃ20m year-on-year, with a further reduction to ยฃ230m post Claremont disposal.
3. **Claremont Financials**: FY 2024 revenue and adjusted EBITDA provided for context, as the disposal impacts future EBITDA.
4. **EBITDA Impact**: Group EBITDA is expected to decrease by ยฃ5m in FY 2025 and ยฃ10m in FY 2026 due to the Claremont disposal. This table provides a clear year-on-year comparison of key financials and debt metrics.